Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Feb 17, 2026 · Filed Feb 18, 2026
TransDigm Group's Co-Chief Operating Officer sold $136K of TransDigm Group shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$136,439
Shares × reported transaction price
14 days after results of Feb 3, 2026, 56 days before results of Apr 14, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,302.11 on Feb 17, 2026, 6% above its 52-week low and 20% below its high, after a 4% drop over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 18% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,358.55 on Jan 2, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.2% | +0.7% | -1.9% |
| 30 days | -13.3% | -4.3% | -9.1% |
| 90 days | -9.9% | +8.3% | -18.2% |
| 180 days | -7.2% | +12.1% | -19.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of TransDigm Group sold $243K of TransDigm Group shares. Nobody planned it ahead of time.
A board member of TransDigm Group sold $611K of TransDigm Group shares. Nobody planned it ahead of time.